CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors

Sadhna Vora(Harvard University), Dejan Juric(Harvard University), Nayoon Kim(Harvard University), Mari Mino–Kenudson(Harvard University), Tiffany G. Huynh(Harvard University), Carlotta Costa(Harvard University), Elizabeth L. Lockerman(Harvard University), Sarah F. Pollack(Harvard University), Manway Liu(Novartis (United States)), Xiaoyan Li(Novartis (United States)), Joseph Lehár(Novartis (United States)), Marion Wiesmann(Novartis (United States)), Markus Wartmann(Novartis (United States)), Yan Chen(Novartis (United States)), Z. Alexander Cao(Novartis (United States)), Maria Pinzon-Ortiz(Novartis (United States)), Sunkyu Kim(Novartis (United States)), Robert Schlegel(Novartis (United States)), Alan Huang(Novartis (China)), Jeffrey A. Engelman(Harvard University)
Cancer Cell
July 1, 2014
10.1016/j.ccr.2014.05.020
Cited by 438Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis